FDA Approves First Biosimilar to Treat Macular Degeneration Disease and Other Eye Conditions ...Middle East

PR Newswire - News
FDA Approves First Biosimilar to Treat Macular Degeneration Disease and Other Eye Conditions
SILVER SPRING, Md., Sept. 20, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Byooviz (ranibizumab-nuna) as the first biosimilar to Lucentis (ranibizumab injection) for the treatment of several eye diseases and conditions, including neovascular (wet) age-related...

Hence then, the article about fda approves first biosimilar to treat macular degeneration disease and other eye conditions was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Biosimilar to Treat Macular Degeneration Disease and Other Eye Conditions )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News